Search for a command to run...
<h3>Background</h3> Syringe drivers (SD) deliver continuous subcutaneous infusions (CSCI) of medication and are regularly used to control symptoms for patients in palliative and end of life (EoL) settings.<sup>1</sup> Patients being discharged from hospital may have their SD stopped, leading to a loss of symptom control while waiting for community services to set up a new SD or have a delayed discharge if community services are unable to meet the need. Alternatively, some hospitals send patients home with a SD, however many end up unreturned, resulting in financial loss to healthcare services. We proposed using an elastomeric pump (EP), a single-use infusion pump that delivers CSCI medication for a 24-hour period, as an alternative device to deliver symptom control medications for palliative and EoL discharge or day-leave. <h3>Methods</h3> Palliative care inpatients on CSCIs leaving a tertiary hospital were prescribed an EP for day-leave, discharge home, or transfer to another care provider, e.g. hospice. The EP contained an identical drug regime to their CSCI. We collected retrospective data over a 12-month period to assess the number of EPs administered, discharge destination, and total number of drugs in the EP. Hospital savings in terms of bed-days saved and loss of hospital pumps were extrapolated from this. <h3>Results</h3> Over 12 months 107 EPs were administered to patients leaving hospital without issue. 16 patients were given 2 EPs to facilitate administration of incompatible drugs. Patients and community services were highly satisfied with the process. Extrapolated costs indicate a potential saving of around £59,000 for a single trust over 12-months. <h3>Conclusions</h3> EPs are a safe, effective, and cost-saving method to deliver CSCI medication for palliative care and EoL patients leaving hospital. We plan to continue using EPs to facilitate discharge for palliative patients and hope to see their use in other patient cohorts. <h3>Reference</h3> Graham F, Clark D. The syringe driver and the subcutaneous route in palliative care: the inventor, the history and the implications. <i>Journal of Pain and Symptom Management</i> 2005;<b>29</b>(1):32–40. doi:10.1016/j.jpainsymman.2004.08.006.